Persistent and recurrent neovascularization after laser photocoagulation for subfoveal choroidal neovascularization of age-related macular degeneration. Macular Photocoagulation Study Group

OBJECTIVE: To determine the incidence and visual impact of and risk factors for persistent and recurrent neovascularization after laser photocoagulation of subfoveal choroidal neovascularization (CNV) in patients with age-related macular degeneration. DESIGN, PATIENTS, AND METHODS: The records of 189 eyes in the Subfoveal New CNV Study and 100 eyes in the Subfoveal Recurrent CNV Study assigned to laser photocoagulation were examined. Persistent CNV (detected within 6 weeks of treatment) and recurrent CNV (detected after 6 weeks) were defined angiographically by fluorescein leakage from the periphery of the treatment scar. Incidence was estimated using survival analysis methods. RESULTS: In both studies, persistent CNV was observed in approximately 13% of the eyes, and recurrent CNV was estimated to have developed by 3 years in an additional 35% of the eyes. In the New CNV Study, by 3 years, 36% of the eyes with persistent CNV had lost 6 or more lines of visual acuity as had 19% of the eyes with recurrent CNV and 27% of the eyes without persistence or recurrence. The presence of neovascular maculopathy in the fellow eye was associated with an increased risk for persistence or recurrence in the study eye. In the New CNV Study, partial coverage of the lesion with heavy laser treatment and/or runoff was associated with increased risk for persistence; less extensive natural scarring of the lesion at study entry was associated with increased risk for recurrence. CONCLUSIONS: Close to half of the eyes treated for subfoveal CNV have persistent or recurrent CNV within 3 years. There is a strong association between neovascular maculopathy in the fellow eye and the inability of laser photocoagulation to permanently obliterate signs of CNV from the study eye. Within these two studies, there was little additional damage to visual function resulting from persistent or recurrent neovascularization. There appears to be no reason to deviate from the protocol goal of covering the entire neovascular complex when treating eyes with subfoveal CNV.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration: Year 1 Results of the FOCUS Study.
Heier et al.
Arch Ophthalmol 2006;124:1532-1542.
ABSTRACT | FULL TEXT  

Evolving European guidance on the medical management of neovascular age related macular degeneration.
Chakravarthy et al.
Br. J. Ophthalmol. 2006;90:1188-1196.
ABSTRACT | FULL TEXT  

Iris Pigment Epithelial Translocation in the Treatment of Exudative Macular Degeneration: A 3-Year Follow-up.
Aisenbrey et al.
Arch Ophthalmol 2006;124:183-188.
ABSTRACT | FULL TEXT  

Outcome of Transplantation of Autologous Retinal Pigment Epithelium in Age-Related Macular Degeneration: A Prospective Trial
Binder et al.
IOVS 2004;45:4151-4160.
ABSTRACT | FULL TEXT  

Radiotherapy for recurrent choroidal neovascularisation complicating age related macular degeneration
Marcus et al.
Br. J. Ophthalmol. 2004;88:114-119.
ABSTRACT | FULL TEXT  

Palladium-103 plaque radiation therapy for macular degeneration: results of a 7 year study
Finger et al.
Br. J. Ophthalmol. 2003;87:1497-1503.
ABSTRACT | FULL TEXT  

The Role of Adult Bone Marrow-Derived Stem Cells in Choroidal Neovascularization
Sengupta et al.
IOVS 2003;44:4908-4913.
ABSTRACT | FULL TEXT  

Retinal Pigment Epithelium Wound Healing in Human Bruch's Membrane Explants
Wang et al.
IOVS 2003;44:2199-2210.
ABSTRACT | FULL TEXT  

Lack of an Association of Apolipoprotein E Gene Polymorphisms With Familial Age-Related Macular Degeneration
Schultz et al.
Arch Ophthalmol 2003;121:679-683.
ABSTRACT | FULL TEXT  

One year follow up of macular translocation with 360 degree retinotomy in patients with age related macular degeneration
Abdel-Meguid et al.
Br. J. Ophthalmol. 2003;87:615-621.
ABSTRACT | FULL TEXT  

Age related macular degeneration
Chopdar et al.
BMJ 2003;326:485-488.
FULL TEXT  

Age-Related Macular Degeneration
Gottlieb
JAMA 2002;288:2233-2236.
FULL TEXT  

Macular Translocation With 360{degrees} Retinotomy for Exudative Age-Related Macular Degeneration
Aisenbrey et al.
Arch Ophthalmol 2002;120:451-459.
ABSTRACT | FULL TEXT  

Targeting of Interferon to Choroidal Neovascularization by Use of Dextran and Metal Coordination
Yasukawa et al.
IOVS 2002;43:842-848.
ABSTRACT | FULL TEXT  

Short-Term Study of Allogeneic Retinal Pigment Epithelium Transplants onto Debrided Bruch's Membrane
Wang et al.
IOVS 2001;42:2990-2999.
ABSTRACT | FULL TEXT  

Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy
Schnurrbusch et al.
Br. J. Ophthalmol. 2001;85:1086-1091.
ABSTRACT | FULL TEXT  

Extracts from "Clinical Evidence": Age related macular degeneration
Arnold and Sarks
BMJ 2000;321:741-744.
FULL TEXT  

Foveal translocation with secondary confluent laser for subfoveal CNV in AMD: 12 month follow up
WONG et al.
Br. J. Ophthalmol. 2000;84:667d-667.
FULL TEXT  

Targeted Delivery of Anti-Angiogenic Agent TNP-470 Using Water-Soluble Polymer in the Treatment of Choroidal Neovascularization
Yasukawa et al.
IOVS 1999;40:2690-2696.
ABSTRACT | FULL TEXT  

Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular Degeneration: Results of a Single Treatment in a Phase 1 and 2 Study
Miller et al.
Arch Ophthalmol 1999;117:1161-1173.
ABSTRACT | FULL TEXT  

Clinicopathological correlation of primary and recurrent choroidal neovascularisation following surgical excision in age related macular degeneration
Castellarin et al.
Br. J. Ophthalmol. 1998;82:480-487.
ABSTRACT | FULL TEXT  

Decreased choriocapillaris perfusion following surgical excision of choroidal neovascular membranes in age-related macular degeneration
Nasir et al.
Br. J. Ophthalmol. 1997;81:481-489.
ABSTRACT | FULL TEXT